Croboride_Holdings_Limited_31_Dec_2024_companies_house_set_of

Croboride Holdings Limited

Report to the board of directors on the preparation of the unaudited statutory financial statements of Croboride Holdings Limited

Year ended

31 December 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the

financial statements

Croboride Holdings Limited

for the year ended

31 December 2024

which comprise the income statement, statement of income and retained earnings, statement of financial position and related notes from the company’s accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at https://www.accaglobal.com/content/dam/ACCA_Global/Members/Doc/rule/2018-rulebook.pdf.

This report is made solely to the Board of Directors of

Croboride Holdings Limited

, as a body, in accordance with the terms of our engagement letter dated 2 January 2025. Our work has been undertaken solely to prepare for your approval the

financial statements

Croboride Holdings Limited

and state those matters that we have agreed to state to the Board of Directors of

Croboride Holdings Limited

, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at https://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/tf-163-jan-24.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than

Croboride Holdings Limited

and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that

Croboride Holdings Limited

has kept adequate accounting records and to prepare statutory

financial statements

that give a true and fair view of the assets, liabilities, financial position and profit of

Croboride Holdings Limited

. You consider that

Croboride Holdings Limited

is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Croboride Holdings Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Emery & Co Accountants Limited

Office Suite 10

The Old Cottage Hospital

Leicester Road

Ashby-De-La-Zouch

LE65 1DB

United Kingdom

Date:

10 April 2025

Croboride Holdings Limited

Statement of Financial Position

31 December 2024

		2024		2023
	Note	£		£
Fixed assets
Investments	5	285,245		285,245
Current assets
Debtors	6	10,010		4,389
Cash at bank and in hand		21,495		107,842
		31,505		112,231
Creditors: amounts falling due within one year	7	(102,660	)	(109,804	)
Net current (liabilities)/assets		(71,155	)	2,427
Total assets less current liabilities		214,090		287,672
Capital and reserves
Called up share capital		1,100		1,100
Profit and loss account		212,990		286,572
Shareholders funds		214,090		287,672

For the year ending

31 December 2024

, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These

financial statements

have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies’ regime.

In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered.

These

financial statements

were approved by the board of directors and authorised for issue on

10 April 2025

, and are signed on behalf of the board by:



Mr D Billings	Mr S Goodfellow	Mr A Stone
Director	Director	Director

Company registration number:

11046879

Croboride Holdings Limited

Notes to the Financial Statements

Year ended

31 December 2024

1 General information

2 Statement of compliance

These

financial statements

have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable to the UK and Republic of Ireland'.

3 Accounting policies

Basis of preparation

The

financial statements

have been prepared on the historical cost basis, as modified by the revaluation of certain assets.

The

financial statements

are prepared in sterling, which is the functional currency of the company.

Judgements and key sources of estimation uncertainty

Judgements and key sources of estimation uncertainty In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Current tax

Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Fixed asset investments

Investments in subsidiaries, associates and joint ventures accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses.

Investments in subsidiaries, associates and joint ventures accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income or profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted.

Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.

Other fixed asset investments which are listed are measured at fair value with changes in fair value being recognised in profit or loss.

All other Investments held as fixed assets are initially recorded at cost, and are subsequently stated at cost less any accumulated impairment losses.

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

Financial instruments

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price and are subsequently measured as follows: Debt instruments are subsequently measured at amortised cost and commitments to receive a loan and to make a loan to another entity are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment.

All other financial instruments, including derivatives, are initially recognised at fair value, which is normally the transaction price and are subsequently measured at fair value, with any changes recognised in profit or loss.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.

All equity instruments regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics.

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

4 Average number of employees

The average number of persons employed by the company during the year was

(2023:

2.00

5 Investments

	Shares in group undertakings and participating interests	Other investments other than loans	Total
	£	£	£
Cost
At 1 January 2024	1,000	284,245	285,245
At 31 December 2024	1,000	284,245	285,245
Impairment
At 1 January 2024 and 31 December 2024	-	-	-
Carrying amount
At 31 December 2024	1,000	284,245	285,245
At 31 December 2023	1,000	284,245	285,245

The Directors have reviewed the value of Other Investments other than Loans and note that there has been no change in value at the year ended 31 December 2024.

The investment is recorded at original cost of £284,245.

6 Debtors

	2024		2023
	£		£
Other debtors	10,010		4,389

7 Creditors: amounts falling due within one year

	2024	2023
	£	£
Trade creditors	147	-
Taxation and social security	25,313	34,290
Other creditors	77,200	75,514
	102,660	109,804

8 Related party transactions

In accordance with the exemption available to small entities under section 1A of FRS102, no disclosure has been made in respect of the transactions with related parties.

9 Controlling party

The ultimate controlling party is the parent company, Croboride Holdings BOT Limited of Rembrandt Works, All Saints Road, Burton-On-Trent, United Kingdom, DE14 3LS.

The company is exempt from preparing group accounts as it is a small group.